Condition

Persistent Pulmonary Hypertension of Newborn clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Persistent Pulmonary Hypertension of Newborn clinical trials that are recruiting, at sites in 2 countries (most in Egypt (2), France (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Persistent Pulmonary Hypertension of Newborn clinical trials

StudyPhaseWhereStatusRegistered
Melatonin plus inhaled nitric oxide for pulmonary hypertension in full-term newborns — Cairo, Abbassia Recruiting Sep 30, 2026
Treprostinil for newborns with persistent pulmonary hypertension — Bron and 3 other locations Recruiting Jul 12, 2024
Nebulized magnesium sulfate and sildenafil for treating newborns with severe pulmonary hypertension Phase 1/2 Sohag Recruiting May 24, 2021

All recruiting trials (3)

Related topics

Congenital Diaphragmatic Hernia

Quick answers

How many Persistent Pulmonary Hypertension of Newborn clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Egypt (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.